SESN2

 Sestrin-2 also known as Hi95 is a protein that in humans is encoded by the SESN2 gene.[4][5][6]

SESN2
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesSESN2, HI95, SES2, SEST2, sestrin 2
External IDsOMIM607767 MGI2651874 HomoloGene12873 GeneCardsSESN2
Gene location (Human)
Chromosome 1 (human)
Chr.Chromosome 1 (human)[1]
Chromosome 1 (human)
Genomic location for SESN2
Genomic location for SESN2
Band1p35.3Start28,259,518 bp[1]
End28,282,491 bp[1]
RNA expression pattern
PBB GE SESN2 gnf1h00495 at fs.png
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_031459

NM_144907

RefSeq (protein)

NP_113647

NP_659156

Location (UCSC)Chr 1: 28.26 – 28.28 Mbn/a
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse

FunctionEdit

This gene encodes a member of the sestrin family of PA26-related proteins. The encoded protein may function in the regulation of cell growth and survival. This protein may be involved in cellular response to different stress conditions.[6][7] The Sestrins constitute a family of evolutionarily-conserved stress-inducible proteins that suppress oxidative stress and regulate adenosine monophosphate-dependent protein kinase (AMPK)-mammalian target of rapamycin (mTOR) signaling. By virtue of these activities, the Sestrins serve as important regulators of metabolic homeostasis. Accordingly, inactivation of Sestrin genes in invertebrates resulted in diverse metabolic pathologies, including oxidative damage, fat accumulation, mitochondrial dysfunction and muscle degeneration that resemble accelerated tissue aging.[6][8]

LigandsEdit

The NMDA receptor antagonist ketamine has been found to activate the mammalian target of rapamycin complex 1 (mTORC1) pathway in the medial prefrontal cortex (mPFC) of the brain as an essential downstream mechanism in the mediation of its rapid-acting antidepressant effects.[9] NV-5138 is a ligand and modulator of sestrin2, a leucine amino acid sensor and upstream regulatory pathway of mTORC1, and is under development for the treatment of depression.[9] The drug has been found to directly and selectively activate the mTORC1 pathway, including in the mPFC, and to produce rapid-acting antidepressant effects similar to those of ketamine.[9]

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License
.